Abstract
An efficient synthesis of dimethyl tripartin as a synthetic precursor of natural product tripartin, the first natural specific inhibitor of histone H3 lysine 9 demethylase KDM4, is described. The synthesis of dimethyl tripartin was achieved in a six-step longest linear sequence starting from commercially available 3,5-dimethoxy benzaldehyde with 21% overall yield, using ClTi(OiPr)3-mediated dichloromethine insertion as the key step.
Introduction
Tripartin (1), a dichlorinated indanone natural product, was isolated in 2013 by Oh group from the culture broth of the Streptomyces sp. associated with larvae of the dung beetle Copris tripartitus Waterhouse.1 It has a tertiary hydroxyl group and a dichloromethine group attached to the C-3 position. In fact, it is the first ever indanone system reported to possess such unique dichlorinated functionality. A total synthesis of tripartin has not been achieved so far (Figure 1).
Figure 1.
Tripartin.
Dynamic methylation and demethylation of arginine and lysine residues of histone protein is a very important biological phenomenon because methylation of different sites can activate or repress genes and therefore regulates transcription.2 Methylation of specific lysine residues is carried out by enzymes known as histone methyltransferases, while the demethylation is carried out by histone demethylases (KDMs). Among the KDM subfamily, humans possess KDM2/7, KDM3, KDM4, KDM5, and KDM6, and these KDMs are often targets for treatment of diseases like leukemia, breast cancer, prostate cancer,3 and inflammation.4 Tripartin is the first natural specific inhibitor of histone H3 lysine 9 demethylase KDM4. Very few KDM selective inhibitors are reported in the literature5 and among those the KDM4 inhibitors are least known, which highlights the unique property of tripartin.
Results and Discussion
Careful observation of the structure of tripartin reveals that it has a very labile moiety at the C-3 position. The site contains a tertiary hydroxy group which is also a benzylic hydroxy group, making it very prone toward elimination. Two types of acidic protons one at α-position of the carbonyl group and another on the dichloromethine group are adjacent to the hydroxyl group, suggesting that the molecule might be quite sensitive toward acidic and basic conditions. This foresight of the problems challenged us to accept the total synthesis of tripartin. In this communication, we report our efforts toward the synthesis of tripartin.
The retrosynthetic analysis of tripartin is shown in Scheme 1. It was envisioned that natural product tripartin 1 could be obtained from the tertiary alcohol 2 by successive deprotections of dithiane and methoxy groups. Compound 2 was planned to be synthesized from indanone derivative 3 by insertion of the dichloromethine group. Compound 3 could be accessed from acid 4, which might be easily obtained from commercially available 3,5-dimethoxy benzaldehyde 5 via 6.
Scheme 1. Retrosynthetic Analysis.
As shown in Scheme 2, the starting point of our synthesis was β-keto ester 6 which was prepared from commercially available 3,5-dimethoxy benzaldehyde by a known two-step protocol.6 Protection of the ketone group using 1,3-propane dithiol followed by saponification of ester 8 gave acid 4, which set the stage for Friedel–Crafts intramolecular cyclization. Several Friedel–Crafts cyclization conditions were employed such as triflic acid, MeSO3H, Tb(OTf)3, Yb(OTf)3, and AlCl3 to cyclize the acid 4 to get indanone 3. Unfortunately, all these attempts were unsuccessful. Interestingly, when the acid chloride 9 was treated with AlCl3, instead of the expected indanone derivative 3, it generated 8-membered ring compound 10 containing two S atoms from the dithiane moiety.
Scheme 2. Synthesis of Compound 10.
Because the dithiane protecting group was interfering with the Friedel–Crafts cyclization, it was decided to use benzyl protection. Unfortunately, benzyl protection of the secondary alcohol 7 was unsuccessful, under various conditions such as NaH/PhCH2Br/–78 °C, CaSO4/Ag2O/PhCH2Br, and Cl3CC(NH)OCH2Ph/BF3·OEt2, in all of the cases either the starting material was recovered or the hydroxyl elimination product was obtained.
It was thought that introduction of ketone functionality could be delayed rather than installing it at the beginning of the synthesis to avoid the complications. Reaching up to the indanone 12 stage seemed easy this way (Scheme 3).
Scheme 3. Retrosynthetic Analysis.
As anticipated, the indanone 12 was accessed without much difficulty starting from 3,5-dimethoxy benzaldehyde 5 using a four-step protocol. Wittig olefination followed by Pd–C catalyzed reduction furnished required ester 15 in excellent yield. Saponification of ester 15 by using LiOH provided acid 13, which was subsequently treated with CH3SO3H to generate required indanone 12 in 85% yield (two steps) (Scheme 4).
Scheme 4. Synthesis of Compound 12.
It was thought that methoxy groups should be deprotected before installing the sensitive tert-hydroxyl group and dichloromethine functionality. Keeping the upcoming sensitive intermediates in mind, deprotection of the methoxy groups of indanone 12 was planned at this stage. Accordingly, indanone 12 on treatment with BBr3 afforded dihydroxy indanone derivative 16. Unfortunately dichloromethine insertion reaction was unsuccessful under basic conditions as shown in Scheme 5. The failure of this reaction might be due to the phenolic hydroxyl group, by decreasing the electrophilic character of the ketone group and rendering it inert toward the nucleophilic attack. Next, the reaction of indanone 12 with dichloromethine anion generated from dichloromethane and n-BuLi resulted in formation of compound 11 in 18% yield. The yield was further improved to 58% using ClTi(OiPr)3 to activate the ketone.7
Scheme 5. Synthesis of Compound 11.
Compound 11 was found to be very unstable with highly labile tertiary alcohol moiety which readily underwent aerial oxidation to generate an epoxide 18 when kept at rt for 6 h. The structure of this epoxide molecule was further confirmed by single-crystal X-ray analysis.8 It was also noticed that the tertiary alcohol 11 undergoes dehydration when stored in CDCl3 for 5 min (Scheme 6).
Scheme 6. Synthesis of Compounds 18 and 19.
After having tertiary alcohol 11 in hand, our next task was benzylic oxidation to install the ketone functionality. Toward this goal, various known oxidation conditions were screened such as NaOCl/t-BuOOH, t-BuOOH/MnO2, KMnO4, and t-BuOOH/Mn(OAc)2, but unfortunately, we observed decomposition of the starting material. Interestingly, compound 11 on treatment with IBX in dimethyl sulfoxide (DMSO) at 80 °C for 12 h afforded compound 20. To our delight, the required keto compound 21 was obtained by employing a KMnO4/MnO2 reagent combination in 46% yield (Scheme 7). As anticipated earlier, the deprotection of methoxy groups proved to be most challenging task at this stage. Various reagents (BBr3, EtSNa, AlCl3, HBr, and dl-methionine/MeSO3H, BCl3) known in the literature for deprotection of methoxy groups were screened. Decomposition of the starting material was the common result of all such attempts.
Scheme 7. Synthesis of Compounds 20 and 21.
It was envisioned that benzyl protection would be more suitable instead of methoxy groups, as it can be removed selectively under hydrogenation conditions. Accordingly, compound 22 was obtained by benzyl protection of the 3,5-dihydroxy indanone 16 in 92% yield. When the dibenzylated indanone 22 was subjected to dichloromethine anion generated from dichloromethane and n-BuLi, the reaction went very smoothly without any difficulty and afforded compound 23 in 51% yield. But contrary to our assumption, deprotection of the benzyl groups was proved to be problematic. Under different types of hydrogenation conditions such as Pd/C/EtOAc, Pd/C/CH2Cl2, Pd/C/MeOH, Pd(OH)2/MeOH, and Pd/C/TBAC/EtOAc, all chlorine atoms, tertiary hydroxyl group, and the benzyl groups were hydrogenated within 5 min. Next, we employed tetrabutylammonium chloride (TBAC)-mediated selective debenzylation in the presence of aromatic chlorine developed by Li group,9 but under this condition compound 25 was isolated, in which chlorine atoms and the tertiary hydroxyl group were hydrogenated and benzyl groups were intact (Scheme 8). Similar results were obtained when catalytic amount of water was added to decrease the reactivity of Pd/C in MeOH. This explains that the hydrogenation of chlorine atoms and hydroxyl group was much faster than the benzyl deprotection.
Scheme 8. Synthesis of Compounds 24 and 25.
Next, hydroxyl groups of indanone 16 were protected as its TBS-ether. Compound 26 was obtained in 82% yield after reaction of the 3,5-dihydroxy indanone 16 with TBSCl and imidazole in dimethylformamide (DMF). When compound 26 was subjected to dichloromethine insertion, the reaction went smoothly to afford compound 27 in 53% yield. To our disappointment, again deprotection of TBS groups using reagents such as HF/Py and TBAF did not afford the desired compound, instead we observed complete decomposition of the starting material. Under LiOAc·2H2O condition, one of the TBS group was cleaved within 1 h to give a hydroxyl compound 28. Unfortunately, the compound was highly unstable, it got decomposed even at 40 °C while evaporating on rotavapor. Benzylic oxidation of compound 28 using KMnO4/MnO2 condition did not yield the expected product this time, and decomposition of the starting material was observed (Scheme 9).
Scheme 9. Synthesis of Compound 28.
As an alternative, acetyl protection was thought to be more suitable anticipating a smooth dichloromethine insertion using excess n-BuLi and CH2Cl2. It was logically assumed that more reactive ketone function would be attacked first by the dichloromethine anion to give tertiary alcohol. Then, the excess dichloromethine anion would attack the carbonyl carbons of two acetyl groups, resulting in their deprotection. Accordingly, compound 29 was synthesized by acetyl protection of the 3,5-dihydroxy indanone 16 in 96% yield. Unfortunately, the successive reaction could lead to an uncharacterizable complex reaction mixture but not the anticipated product (Scheme 10).
Scheme 10. Synthesis of Compound 29.
Next, hydroxyl groups of indanone 16 were protected with allyl groups. Compound 31 was obtained in 90% yield after reaction of the 3,5-dihydroxy indanone 16 with allyl bromide and K2CO3 in DMF. When compound 31 was subjected to dichloromethine insertion, the reaction went smoothly to afford compound 32 in 50% yield. To our disappointment benzylic oxidation of compound 32 using KMnO4/MnO2 condition did not yield the expected product, and decomposition of the starting material was observed. Unfortunately, allyl deprotection of compound 32 was unsuccessful, under various conditions such as Pd(PPh3)4/LiBH4, Pd(PPh3)4/K2CO3, Pd/C/KOH, and SmI2/H2O/i-PrNH2, in all of the cases either starting material was recovered or decomposed (Scheme 11).
Scheme 11. Synthesis of Compound 32.
Conclusion
In conclusion, the first synthetic effort toward the synthesis of tripartin has been reported. A short route to dimethyl tripartin was accomplished in six steps with 21% overall yield starting from commercially available 3,5-dimethoxy benzaldehyde using ClTi(OiPr)3-mediated dichloromethine insertion as a key step.
Experimental Section
General Information
Reagents were purchased at the highest commercial quality and used without further purification, unless otherwise stated. NMR spectra were recorded on either a Bruker AVANCE 200 (1H: 200 MHz, 13C: 50 MHz), Bruker AVANCE 400 (1H: 400 MHz, 13C: 100 MHz), Bruker AVANCE 500 (1H: 500 MHz, 13C: 125 MHz), or JEOL ECX 500 (1H: 500 MHz, 13C: 125 MHz). Mass spectrometric data were obtained using WATERS-Q-Tof Premier-ESI-MS.
The single crystal X-ray diffraction intensity data collection for the crystals of compound 18 was carried out on a Bruker APEX-II CCD detector system with Mo-sealed Siemens ceramic diffraction tube (λ = 0.7107 Å) and a highly oriented graphite monochromator operating at 50 kV and 30 mA. The data were collected in a hemisphere mode and processed with Bruker SAINT. Empirical absorption correction was made using Bruker SADABS. The structure was solved by using SHELXL package and refined by full matrix least-squares method based on F2 using SHELX-2017 program (Sheldrick 2017). Hydrogens were fixed geometrically, treated as riding on their nonhydrogens, and refined isotropically, while all nonhydrogens were subjected to anisotropic refinement.
The following abbreviations were used to explain the multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, dd = doublet of doublet, ddd = doublet of a doublet of a doublet, dm = doublet of a multiplet, m = multiplet, and br = broad.
Ethyl 2-(2-(3,5-Dimethoxyphenyl)-1,3-dithian-2-yl)acetate (8)
BF3·OEt2 (0.6 mL, 5 mmol) was slowly added to the mixture of β-keto ester 6 (500 mg, 2 mmol) and 1,3-propane dithiol (0.8 mL, 8 mmol) in CH2Cl2 at 0 °C. After being stirred at 0 °C for 1 h and room temperature for 12 h, the reaction was quenched by adding 1 M NaOH and the mixture was extracted with Et2O three times. The organic phase was washed with 1 M NaOH three times and dried over MgSO4. Evaporation of the solvent and purification of the residue on a silica gel column furnished the product 8 (651 mg, 96%) as a colorless liquid; Rf = 0.4 (EtOAc–hexane 1:19); IR (neat) νmax/cm–1: 2936, 2906, 2835, 1734, 1594, 1455, 1422, 1307, 1286, 1203, 1191, 1155, 1067, 838, 697; 1H NMR (400 MHz, chloroform-d): δ 7.12 (d, J = 2.2 Hz, 2H), 6.37 (t, J = 2.2 Hz, 1H), 3.98 (q, J = 7.2 Hz, 2H), 3.78 (s, 6H), 2.99 (s, 2H), 2.78–2.71 (m, 4H), 1.96–1.89 (m, 2H), 1.08 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, chloroform-d): δ 167.8, 160.8, 143.2, 106.7, 99.2, 60.5, 55.4, 55.3, 49.1, 27.9, 24.3, 13.8; HRMS-ESI m/z: calcd for C16H23O4S2 [M + H], 343.1038; found, 343.1039.
(Z)-4-(3,5-Dimethoxyphenyl)-7,8-dihydro-1,5-dithiocin-2(6H)-one (10)
To a solution of ester 8 (100 mg, 0.3 mmol) in tetrahydrofuran (THF) (8 mL), an aqueous solution (2 mL) of LiOH (35 mg, 1.5 mmol) was added. The reaction was monitored using TLC and on completion was quenched with 1 N HCl. The organic layer was separated and the aqueous layer was extracted with ethyl acetate. The organic layer was dried over Na2SO4 and concentrated under reduced pressure to give the acid 4. To a solution of crude acid 4 in CH2Cl2 at 0 °C was added oxalyl chloride (0.4 mL, 0.5 mmol) slowly, followed by 2–3 drops of DMF. The resulting mixture was stirred at 0 °C for 1 h. After concentration of the reaction mixture, the crude residue was dissolved in CH2Cl2, cooled to 0 °C, and AlCl3 (42 mg, 0.3 mmol) was added in portion wise. After stirring for 1 h, the reaction mixture was quenched with aq NaHCO3 and the layers were separated. The aqueous layer was extracted with Et2O and the combined organic extracts were washed with H2O, saturated NaHCO3, and brine and dried over Na2SO4. Evaporation of the solvent and purification of the residue on silica gel column furnished the product 10 (52 mg, 55%) as a colorless liquid; Rf = 0.5 (EtOAc–hexane 1:19); IR (neat) νmax/cm–1: 2927, 2838, 1592, 1454, 1422, 1344, 1321, 1297, 1258, 1205, 1155, 1107, 1064, 839, 803; 1H NMR (400 MHz, chloroform-d): δ 6.67 (dd, J = 1.4, 2.3 Hz, 2H), 6.53–6.45 (m, 1H), 6.18 (s, 1H), 3.81 (s, 6H), 3.54 (br s, 2H), 3.29 (br s, 2H), 2.27 (quin, J = 5.6 Hz, 2H); 13C NMR (125 MHz, chloroform-d): δ 197.1 (C=O), 160.7 (C), 149.2 (C), 141.9 (C), 121.8 (CH), 105.5 (CH), 101.6 (CH), 55.5 (CH3), 33.0 (CH2), 30.5 (CH2), 28.8 (CH2); HRMS-ESI m/z: calcd for C14H17O3S2 [M + H], 297.0619; found, 297.0610.
(E)-Ethyl 3-(3,5-Dimethoxyphenyl)acrylate (14)
To a solution of aldehyde 5 (5 g, 30.1 mmol) in anhydrous CH2Cl2 was added dry Ph3P=CHCO2Et (12.6 g, 36.1 mmol) and stirred magnetically for 4 h at rt. Evaporation of the solvent and purification of the residue on silica gel column furnished the product 14 (7 g, 98%) as a colorless liquid; Rf = 0.3 (EtOAc–hexane 1:10); IR (neat) νmax/cm–1: 2939, 2840, 1712, 1640, 1593, 1460, 1282, 1177, 1158, 1207; 1H NMR (400 MHz, chloroform-d): δ 7.61 (d, J = 16.0 Hz, 1H), 6.67 (d, J = 2.3 Hz, 2H), 6.50 (t, J = 2.3 Hz, 1H), 6.41 (d, J = 16.0 Hz, 1H), 4.27 (q, J = 7.1 Hz, 2H), 3.81 (s, 6H), 1.34 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, chloroform-d): δ 166.9, 161.0, 144.6, 136.3, 118.7, 105.9, 102.5, 60.5, 55.4, 14.3; HRMS-ESI m/z: calcd for C13H17O4 [M + H], 237.1127; found, 237.1129.
Ethyl 3-(3,5-Dimethoxyphenyl)propanoate (15)
Compound 14 (6 g, 25.4 mmol) was dissolved in MeOH and 10% palladium on activated carbon was added. The reaction was stirred under H2 at rt overnight, whereupon TLC showed that the reaction was complete. The solid was filtered off. Evaporation of the solvent and purification of the residue on silica gel column furnished the product 15 (5.8 g, 96%) as a colorless liquid; Rf = 0.3 (EtOAc–hexane 1:10); IR (neat) νmax/cm–1: 2939, 2839, 1732, 1597, 1463, 1430, 1206, 1154, 1069, 834, 692; 1H NMR (400 MHz, chloroform-d): δ 6.37 (d, J = 2.3 Hz, 2H), 6.32 (t, J = 2.3 Hz, 1H), 4.14 (q, J = 7.1 Hz, 2H), 3.78 (s, 6H), 2.90 (t, J = 7.9 Hz, 2H), 2.61 (t, J = 7.9 Hz, 2H), 1.26 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, chloroform-d): δ 172.9, 160.8, 142.9, 106.3, 98.2, 60.4, 55.2, 35.8, 31.2, 14.2; HRMS-ESI m/z: calcd for C13H19O4 [M + H], 239.1283; found, 239.1287.
5,7-Dimethoxy-2,3-dihydro-1H-inden-1-one (12)
To a solution of ester 15 (5.5 g, 23.1 mmol) in THF (20 mL), an aqueous solution (5 mL) of LiOH (1.7 g, 69.3 mmol) was added. The reaction was monitored using TLC and on completion was quenched with 1 N HCl. The organic layer was separated and the aqueous layer was extracted with ethyl acetate. The organic layer was dried over Na2SO4 and concentrated under reduced pressure to give the acid 13. Crude carboxylic acid 13 and methanesulfonic acid (13 mL, 196 mmol) were combined and heated to 95 °C for 6 h. On completion of the reaction, which was monitored by TLC, the reaction mixture was poured over crushed ice. NaOH was added to neutralize methanesulfonic acid. The aqueous layer was extracted with ethyl acetate. The entire organic portion was washed with brine and dried over Na2SO4. Evaporation of the solvent and purification of the residue on silica gel column furnished the product 12 (4.3 g, 85%) as a solid, mp 99–100 °C; Rf = 0.2 (EtOAc–hexane 1:1); IR (KBr) νmax/cm–1: 2945, 2839, 1691, 1601, 1471, 1326, 1215, 1155, 1086, 1021; 1H NMR (400 MHz, chloroform-d): δ 6.47 (s, 1H), 6.29 (s, 1H), 3.89 (s, 3H), 3.86 (s, 3H), 3.03–2.98 (m, 2H), 2.66–2.60 (m, 2H); 13C NMR (100 MHz, chloroform-d): δ 203.1, 166.9, 160.4, 159.3, 119.4, 101.6, 97.3, 55.7, 55.6, 36.9, 25.9; HRMS-ESI m/z: calcd for C11H13O3 [M + H], 193.0865; found, 193.0860.
1-(Dichloromethyl)-5,7-dimethoxy-2,3-dihydro-1H-inden-1-ol (11)
To a solution of dry CH2Cl2 (3 mL, 36.4 mmol) in dry THF (20 mL), n-BuLi (16 mL, 26.4 mmol, 1.6 M in hexane) was added very slowly under argon atmosphere at −100 °C. After the addition was complete, the mixture was stirred at −100 °C for 1 h. A mixture of compound 12 (1.0 g, 5.2 mmol) and TiCl(OiPr)3 (1.2 mL, 5.2 mmol) in dry THF was added slowly and stirred at −100 °C for 2 h. After 2 h, the reaction mixture was allowed to warm to −20 °C and poured into an ice water. Et2O was added and the layers were separated. The aqueous layer was extracted with ether (two times). The combined organic layers were dried over Na2SO4. Evaporation of the solvent and purification of the residue on a silica gel column furnished the product 11 (833 mg, 58%) as a white solid; mp 53–55 °C; Rf = 0.3 (EtOAc–hexane 1:4); IR (neat) νmax/cm–1: 3380, 3010, 2942, 2843, 1601, 1493, 1464, 1340, 1216, 1153, 1080, 830, 790; 1H NMR (400 MHz, DMSO-d6): δ 6.60 (s, 1H), 6.39 (s, 1H), 6.36 (s, 1H), 5.82 (s, 1H), 3.77 (s, 3H), 3.74 (s, 3H), 2.97 (td, J = 8.2, 16.3 Hz, 1H), 2.79 (ddd, J = 2.7, 9.1, 16.3 Hz, 1H), 2.58 (ddd, J = 7.7, 9.1, 13.6 Hz, 1H), 2.08 (ddd, J = 2.7, 8.6, 13.6 Hz, 1H); 13C NMR (100 MHz, DMSO-d6): δ 161.9 (C), 156.6 (C), 147.1 (C), 123.0 (C), 100.9 (CH), 97.1 (CH), 87.2 (C), 78.3 (CH), 55.4 (CH3), 55.3 (CH3), 34.0 (CH2), 29.5 (CH2); HRMS-ESI m/z: calcd for C12H13Cl2O2 [M – OH]. 259.0293; found, 259.0294.
Compound 18
Red color solid, mp 49–51 °C; Rf = 0.4 (EtOAc–hexane 1:9); IR (KBr) νmax/cm–1: 2927, 2852, 1673, 1604, 1461, 1228, 1152, 1070, 898, 823, 781, 764, 725; 1H NMR (400 MHz, chloroform-d): δ 6.33 (s, 1H), 6.27 (s, 1H), 5.80 (d, J = 1.6 Hz, 1H), 3.83 (s, 3H), 2.62–2.51 (m, 4H); 13C NMR (100 MHz, chloroform-d): δ 186.6 (C=O), 164.2 (C), 156.6 (C), 126.7 (CH), 108.0 (CH), 78.9 (C), 69.0 (CH), 65.9 (C), 56.4 (CH3), 24.8 (CH2), 24.7 (CH2); HRMS-ESI m/z: calcd for C11H11Cl2O3 [M + H], 261.0085; found, 261.0086.
3-(Dichloromethyl)-4,6-dimethoxy-1H-indene (19)
Colorless liquid; Rf = 0.3 (EtOAc–hexane 1:19); IR (neat) νmax/cm–1: 2966, 2925, 2851, 2839, 1605, 1575, 1486, 1433, 1465, 1455, 1328, 1298, 1213, 1154, 1093, 1072, 838, 814, 674; 1H NMR (400 MHz, chloroform-d): δ 7.13 (d, J = 0.9 Hz, 1H), 6.76 (s, 1H), 6.69 (s, 1H), 6.44 (d, J = 1.8 Hz, 1H), 3.89 (s, 3H), 3.84 (s, 3H), 3.44 (s, 2H); 13C NMR (100 MHz, chloroform-d): δ 160.0, 154.1, 147.5, 143.4, 129.8, 122.4, 101.9, 97.4, 67.1, 55.6, 55.5, 38.2; HRMS-ESI m/z: calcd for C12H13Cl2O2 [M + H], 259.0293; found, 259.0296.
1-(Dichloromethyl)-5,7-dimethoxy-1H-inden-1-ol (20)
To a solution of compound 11 (30 mg, 0.1 mmol) in DMSO, IBX (45 mg, 0.2 mmol) was added and stirred at 80 °C for 12 h. The reaction was monitored by TLC on completion, the reaction mixture was cooled and diluted with ether. The organic layer was washed with saturated NaHCO3 solution and with water, dried over Na2SO4. Evaporation of the solvent and purification of the residue on a silica gel column furnished the product 20 (11 mg, 36%) as a yellow color solid, mp 46–48 °C; Rf = 0.5 (EtOAc–hexane 1:6); IR (neat) νmax/cm–1: 3434, 3097, 2944, 2843, 1615, 1594, 1467, 1369, 1309, 1105, 1078, 963, 837, 802, 713; 1H NMR (400 MHz, chloroform-d): δ 7.36 (s, 1H), 6.87 (d, J = 5.5 Hz, 1H), 6.79 (dd, J = 1.6, 5.5 Hz, 1H), 6.54 (d, J = 2.1 Hz, 1H), 6.35 (d, J = 1.8 Hz, 1H), 3.92 (s, 3H), 3.85 (s, 3H); 13C NMR (125 MHz, chloroform-d): δ 161.3 (C), 156.0 (C), 145.5 (C), 141.2 (C), 133.0 (CH), 126.2 (CH), 121.2 (CH), 114.3 (C), 99.8 (CH), 96.2 (CH), 55.6 (CH3), 55.2 (CH3); HRMS-ESI m/z: calcd for C12H11Cl2O2 [M – OH], 257.0136; found, 257.0138.
3-(Dichloromethyl)-3-hydroxy-4,6-dimethoxy-2,3-dihydro-1H-inden-1-one (21)
To a solution of compound 11 (50 mg, 0.2 mmol) in CH2Cl2, finely ground KMnO4/MnO2 reagent (5:1 mole ratio) was added in small portions over a period of 15 min. The mixture was stirred vigorously at rt and while the progress of the reaction was monitored by TLC. After 5 days, the reaction mixture was filtered through a sintered glass funnel to remove spent oxidant. The residue was then washed with ethyl acetate. Evaporation of the solvent and purification of the residue on a silica gel column furnished the product 21 (24 mg, 46%) as a colorless liquid and also starting material (55 mg) was recovered; Rf = 0.3 (EtOAc–hexane 1:3); IR (neat) νmax/cm–1: 3432, 2928, 2842, 1719, 1614, 1492, 1347, 1313, 1206, 1153, 1037, 796; 1H NMR (400 MHz, chloroform-d): δ 6.82 (d, J = 2.0 Hz, 1H), 6.71 (d, J = 2.0 Hz, 1H), 6.48 (s, 1H), 3.94 (s, 3H), 3.86 (s, 3H), 3.42 (d, J = 18.9 Hz, 1H), 2.81 (d, J = 18.9 Hz, 1H); 13C NMR (100 MHz, chloroform-d): δ 200.9 (C=O), 163.5 (C), 156.8 (C), 140.2 (C), 132.5 (C), 106.1 (CH), 96.9 (CH), 81.4 (C), 76.0 (CH), 56.0 (CH3), 55.9 (CH3), 47.3 (CH2); HRMS-ESI m/z: calcd for C12H13Cl2O4 [M + H], 291.0191; found, 291.0190.
5,7-Bis(benzyloxy)-2,3-dihydro-1H-inden-1-one (22)
To a solution of compound 16(9) (500 mg, 3.0 mmol) in dry DMF, BnBr (2.2 mL, 18.3 mmol) and K2CO3 (2.5 g, 18.3 mmol) were added and stirred at 80 °C for 3 h. Cold H2O was added, and the mixture was stirred until all of the carbonate dissolved. The solution was acidified with HCl and then extracted with EtOAc three times. The combined organic layers were washed with H2O and dried over Na2SO4. Evaporation of the solvent and purification of the residue on a silica gel column furnished the product 22 (965 mg, 92%) as a colorless liquid; Rf = 0.4 (EtOAc–hexane 1:2); IR (neat) νmax/cm–1: 3031, 2921, 1696, 1598, 1320, 1160, 736, 696; 1H NMR (400 MHz, chloroform-d): δ 7.49 (d, J = 7.3 Hz, 2H), 7.44–7.33 (m, 7H), 7.31 (d, J = 7.3 Hz, 1H), 6.56 (s, 1H), 6.41 (d, J = 1.8 Hz, 1H), 5.23 (s, 2H), 5.07 (s, 2H), 3.06–2.98 (m, 2H), 2.70–2.62 (m, 2H); 13C NMR (100 MHz, chloroform-d): δ 202.7, 165.7, 160.2, 158.1, 136.3, 135.9, 128.6, 128.5, 128.2, 127.7, 127.5, 126.5, 120.0, 103.0, 99.7, 70.3, 69.9, 36.9, 25.8; HRMS-ESI m/z: calcd for C23H21O3 [M + H], 345.1491; found, 345.1492.
5,7-Bis(benzyloxy)-1-(dichloromethyl)-2,3-dihydro-1H-inden-1-ol (23)
According to the procedure for the synthesis of compound 11, compound 22 (500 mg, 1.4 mmol), dry CH2Cl2 (0.6 mL, 10.2 mmol), n-BuLi (5.4 mL, 8.7 mmol, 1.6 M in hexane), and TiCl(OiPr)3 (0.4 mL, 1.4 mmol) were used to furnish the product 23 (317 mg, 51%) as a colorless liquid; Rf = 0.5 (EtOAc–hexane 1:4); IR (neat) νmax/cm–1: 3561, 3063, 3031, 2929, 1602, 1453, 1325, 1218, 1148, 1069, 1028, 734, 696; 1H NMR (400 MHz, DMSO-d6): δ 7.51–7.46 (m, 2H), 7.45–7.30 (m, 8H), 6.56 (s, 1H), 6.51 (d, J = 2.7 Hz, 2H), 5.93 (s, 1H), 5.12 (s, 2H), 5.06 (s, 2H), 2.97 (td, J = 8.2, 16.2 Hz, 1H), 2.79 (ddd, J = 2.2, 9.3, 16.2 Hz, 1H), 2.62–2.52 (m, 1H), 2.08 (ddd, J = 2.4, 8.5, 13.7 Hz, 1H); 13C NMR (100 MHz, DMSO-d6): δ 160.8 (C), 155.4 (C), 147.3 (C), 137.1 (C), 137.0 (C), 128.5 (CH), 128.4 (CH), 127.9 (CH), 127.8 (CH), 127.7 (CH), 127.4 (CH), 123.4 (C), 102.1 (CH), 99.0 (CH), 87.2 (C), 78.2 (CH), 69.4 (CH2), 34.0 (CH2), 29.4 (CH2); HRMS-ESI m/z: calcd for C24H21Cl2O2 [M – OH], 411.0919; found, 411.0925.
3-Methyl-2,3-dihydro-1H-indene-4,6-diol (24)
According to the procedure for the synthesis of compound 15, compound 23 (50 mg, 0.1 mmol) and 5% Pd/C were used to furnish the product 24 (12 mg, 65%) as a colorless liquid; Rf = 0.3 (EtOAc–hexane 1:4); IR (neat) νmax/cm–1: 3381, 2952, 2925, 2851, 1600, 1463, 1335, 1251, 1127, 1025, 836; 1H NMR (400 MHz, chloroform-d): δ 6.30 (s, 1H), 6.14 (d, J = 1.8 Hz, 1H), 3.32–3.25 (m, 1H), 2.93 (td, J = 8.1, 16.0 Hz, 1H), 2.74 (ddd, J = 4.4, 9.0, 16.0 Hz, 1H), 2.32–2.23 (m, 1H), 1.71 (m, 1H), 1.24 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, chloroform-d): δ 155.6 (C), 152.6 (C), 147.2 (C), 126.3 (C), 104.1 (CH), 100.8 (CH), 36.2 (CH), 34.1 (CH2), 31.5 (CH2), 19.8 (CH3); HRMS-ESI m/z: calcd for C10H13O2 [M + H], 165.0916; found, 165.0920.
5,7-Bis(benzyloxy)-1-methyl-2,3-dihydro-1H-indene (25)
To a magnetically stirred solution of compound 23 (50 mg, 0.1 mmol) in CH2Cl2 was added TBAC (161 mg, 0.6 mmol) and 5% palladium on activated carbon. The reaction was stirred under H2 at rt overnight, whereupon TLC showed that the reaction was complete. The solid was filtered off. Evaporation of the solvent and purification of the residue on a silica gel column furnished the product 25 (18 mg, 45%) as a colorless liquid; Rf = 0.4 (EtOAc–hexane 1:19); IR (neat) νmax/cm–1: 3031, 2950, 2863, 1597, 1487, 1453, 1434, 1375, 1309, 1167, 1139, 1067, 734, 696; 1H NMR (500 MHz, chloroform-d): δ 7.48–7.42 (m, 4H), 7.40 (dt, J = 1.7, 7.4 Hz, 4H), 7.37–7.31 (m, 2H), 6.49 (s, 1H), 6.45 (s, 1H), 5.06 (s, 2H), 5.03 (s, 2H), 3.43–3.35 (m, 1H), 2.99 (td, J = 8.0, 16.0 Hz, 1H), 2.83–2.76 (m, 1H), 2.34–2.25 (m, 1H), 1.75–1.70 (m, 1H), 1.29 (d, J = 6.9 Hz, 3H); 13C NMR (125 MHz, chloroform-d): δ 159.4 (C), 155.9 (C), 146.2 (C), 137.4 (C), 137.3 (C), 129.1 (C), 128.6 (CH), 128.5 (CH), 127.9 (CH), 127.7 (CH), 127.5 (CH), 127.1 (CH), 102.1 (CH), 98.6 (CH), 70.3 (CH2), 69.6 (CH2), 37.1 (CH), 33.9 (CH2), 31.8 (CH2), 20.0 (CH3); HRMS-ESI m/z: calcd for C24H25O2 [M + H], 345.1855; found, 345.1861.
5,7-Bis(tert-butyldimethylsilyloxy)-2,3-dihydro-1H-inden-1-one (26)
To a solution of ketone 16 (500 mg, 3.0 mmol) dissolved in DMF, cooled to 0 °C, imidazole (1.1 g, 15.8 mmol) followed by TBDMSCl (1.2 g, 8 mmol) was added and stirred overnight. On completion of the reaction, DMF was evaporated, and the reaction mixture was quenched with water and extracted with CH2Cl2 (3 × 15 mL). The entire organic layer was washed with brine and dried over Na2SO4. Evaporation of the solvent and purification of the residue on a silica gel column furnished the product 26 (980 mg, 82%) as a colorless liquid; Rf = 0.3 (EtOAc–hexane 1:19); IR (neat) νmax/cm–1: 2955, 2930, 2858, 1712, 1596, 1468, 1347, 1196, 1160, 832, 781; 1H NMR (400 Mz, chloroform-d): δ 6.47 (s, 1H), 6.18 (d, J = 1.8 Hz, 1H), 3.00–2.92 (m, 2H), 2.61–2.55 (m, 2H), 1.05 (s, 9H), 0.99 (s, 9H), 0.24 (s, 12H); 13C NMR (100 MHz, chloroform-d): δ 202.7, 162.7, 158.9, 155.3, 122.4, 110.9, 110.8, 36.9, 25.7, 25.6, 25.4, 18.4, 18.3, −3.6, −4.3, −4.5; HRMS-ESI m/z: calcd for C21H37O3Si2 [M + H], 393.2281; found, 393.2285.
5,7-Bis(tert-butyldimethylsilyloxy)-1-(dichloromethyl)-2,3-dihydro-1H-inden-1-ol (27)
According to the procedure for the synthesis of compound 11, compound 26 (500 mg, 1.3 mmol), dry CH2Cl2 (0.6 mL, 8.9 mmol), n-BuLi (5 mL, 7.6 mmol, 1.6 M in hexane), and TiCl(OiPr)3 (0.3 mL, 1.3 mmol) were used to furnish the product 27 (321 mg, 53%) as a colorless liquid; Rf = 0.5 (EtOAc–hexane 1:9); IR (neat) νmax/cm–1: 3352, 2930, 2858, 1592, 1471, 1346, 1256, 1152, 1057, 1006, 833, 782; 1H NMR (400 MHz, acetonitrile-d3): δ 6.57 (s, 1H), 6.37 (s, 1H), 6.18 (s, 1H), 3.73 (s, 1H), 3.02–2.93 (m, 1H), 2.83 (ddd, J = 3.8, 9.3, 16.3 Hz, 1H), 2.76–2.67 (m, 1H), 2.10 (ddd, J = 3.8, 8.9, 13.9 Hz, 1H), 1.03 (s, 9H), 0.97 (s, 9H), 0.30 (s, 3H), 0.29 (s, 3H), 0.20 (s, 6H); 13C NMR (125 MHz, acetonitrile-d3): δ 158.8, 153.7, 149.3, 126.3, 110.4, 109.7, 88.9, 78.7, 35.3, 30.6, 26.3, 26.1, 19.0, 18.9, −3.7, −3.9, −4.1; HRMS-ESI m/z: calcd for C22H37Cl2O2Si2 [M – OH], 459.1710; found, 459.1709.
7-(tert-Butyldimethylsilyloxy)-1-(dichloromethyl)-2,3-dihydro-1H-indene-1,5-diol (28)
To a solution of compound 27 (30 mg, 0.1 mmol) in DMF–H2O (50:1, 2.0 mL) under argon, LiOAc dihydrate (19 mg, 0.2 mmol) was added, and the solution was stirred at rt until all of the starting material has been consumed. The mixture was cooled to rt, diluted with ether. The entire organic layer was washed with brine and dried over Na2SO4. Evaporation of the solvent and purification of the residue on a silica gel column furnished the product 28 (9 mg, 42%) as a colorless liquid; Rf = 0.4 (EtOAc–hexane 1:4); IR (neat) νmax/cm–1: 3356, 2929, 2852, 1590, 1462, 1360, 1242, 1046, 1015, 845, 776; 1H NMR (400 MHz, acetonitrile-d3): δ 7.27 (s, 1H), 6.51 (s, 1H), 6.28–6.27 (m, 1H), 6.18–6.17 (m, 1H), 3.87 (s, 1H), 2.96–2.89 (m, 1H), 2.87–2.80 (m, 1H), 2.73–2.66 (m, 1H), 2.14–2.07 (m, 1H), 0.97 (s, 9H), 0.20 (s, 6H);13C NMR (125 MHz, acetonitrile-d3): δ 156.5, 151.8, 149.1, 144.2, 131.3, 110.1, 106.8, 68.4, 38.8, 26.2, 26.1, 19.0, −4.2; HRMS-ESI m/z: calcd for C16H23Cl2O2Si [M – OH], 345.0845; found, 345.0851.
3-Oxo-2,3-dihydro-1H-indene-4,6-diyl Diacetate (29)
To a solution of ketone 16 (200 mg, 1.2 mmol) in CH2Cl2, triethylamine (0.85 mL, 6 mmol) was added. The mixture was stirred for 5 min at 0 °C then acetyl chloride (0.26 mL, 3.6 mmol) was added dropwise and was stirred overnight. The reaction was quenched with water, the organic layer was separated and aqueous layer was extracted with CH2Cl2 (2 × 20 mL). The entire organic layer was washed with brine and dried over Na2SO4, then concentrated, and purified using column chromatography to obtain the product 29 (289 mg, 96%); Rf = 0.6 (EtOAc–hexane 1:1); 1H NMR (400 MHz, chloroform-d): δ 7.13 (s, 1H), 6.78 (s, 1H), 3.16–3.11 (m, 2H), 2.71–2.67 (m, 2H), 2.39 (s, 3H), 2.33 (s, 3H); 13C NMR (100 MHz, chloroform-d): δ 202.4, 168.8, 168.4, 157.9, 156.3, 148.2, 126.3, 117.2, 114.9, 36.8, 25.7, 21.1, 20.7; HRMS-ESI m/z: calcd for C13H13O5 [M + H], 249.0763; found, 249.0757.
5,7-Bis(allyloxy)-2,3-dihydro-1H-inden-1-one (31)
To a solution of compound 16 (400 mg, 2.4 mmol) in dry DMF, allyl bromide (1.0 mL, 9.7 mmol) and K2CO3 (1.0 g, 7.3 mmol) were added and stirred at rt for 20 h. Cold H2O was added and the mixture was stirred until all of the carbonate dissolved. The solution was acidified with HCl and then extracted with EtOAc three times. The combined organic layers were washed with H2O and dried over Na2SO4. Evaporation of the solvent and purification of the residue on a silica gel column furnished the product 31 (535 mg, 90%) as a colorless liquid; Rf = 0.4 (EtOAc–hexane 1:4); 1H NMR (400 MHz, chloroform-d): δ 6.45 (s, 1H), 6.30 (s, 1H), 6.10–5.96 (m, 2H), 5.48 (td, J = 1.1, 17.2 Hz, 1H), 5.40 (td, J = 1.4, 17.2 Hz, 1H), 5.29 (tdd, J = 1.1, 6.1, 10.6 Hz, 2H), 4.64 (dd, J = 1.4, 5.0 Hz, 2H), 4.56 (dd, J = 1.4, 5.0 Hz, 2H), 3.02–2.93 (m, 2H), 2.64–2.57 (m, 2H); 13C NMR (100 MHz, chloroform-d): δ 202.6, 165.5, 160.1, 158.1, 132.2, 119.7, 118.2, 117.8, 102.6, 99.1, 99.0, 69.0, 36.8, 25.8; HRMS-ESI m/z: calcd for C15H17O3 [M + H], 245.1178; found, 245.1174.
5,7-Bis(allyloxy)-1-(dichloromethyl)-2,3-dihydro-1H-inden-1-ol (32)
According to the procedure for the synthesis of compound 11, compound 31 (318 mg, 1.3 mmol), dry CH2Cl2 (0.6 mL, 8.9 mmol), n-BuLi (5 mL, 7.6 mmol, 1.6 M in hexane), and TiCl(OiPr)3 (0.3 mL, 1.3 mmol) were used to furnish the product 32 (210 mg, 50%) as a colorless liquid; Rf = 0.5 (EtOAc–hexane 1:9); 1H NMR (500 MHz, chloroform-d): δ 6.47 (s, 1H), 6.38 (br s, 1H), 6.33 (br s, 1H), 6.14–5.96 (m, 2H), 5.41 (d, J = 17.2 Hz, 2H), 5.32 (dd, J = 10.9, 14.9 Hz, 2H), 4.59 (s, 2H), 4.51 (s, 2H), 3.14–3.00 (m, 2H), 2.99–2.81 (m, 2H), 2.22 (br s, 1H); 13C NMR (100 MHz, chloroform-d): δ 158.8, 153.0, 147.6, 143.4, 133.2, 133.0, 130.0, 122.7, 117.9, 117.8, 103.1, 99.1, 69.3, 69.2, 67.1, 38.1; HRMS-ESI m/z: calcd for C16H17Cl2O2 [M – OH], 311.0606; found, 311.0602.
Acknowledgments
R.B. thanks CSIR, New Delhi, for the award of research fellowship. The financial support from IIT Kanpur is gratefully acknowledged. The financial support from DST, New Delhi, (Project no. SB/S1/OC-01/2014) is gratefully acknowledged. We thank Ashish Singh from IIT Kanpur for his assistance in solving the crystal structure.
Supporting Information Available
The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.8b01341.
The authors declare no competing financial interest.
Supplementary Material
References
- a Kim S.-H.; Kwon S. H.; Park S.-H.; Lee J. K.; Bang H.-S.; Nam S.-J.; Kwon H. C.; Shin J.; Oh D.-C. Tripartin, a histone demethylase inhibitor from a bacterium associated with a dung beetle larva. Org. Lett. 2013, 15, 1834–1837. 10.1021/ol4004417. [DOI] [PubMed] [Google Scholar]; b OH D.-C.; Kim S.-H.; Shin J.; Kwon H. C.; Kwon S. H.. Novel compound, preparing method thereof, and use thereof as inhibitors of histone demethylase. U.S. Patent 20,150,133,564 A1, 2015.
- Martin C.; Zhang Y. The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell Biol. 2005, 6, 838–849. 10.1038/nrm1761. [DOI] [PubMed] [Google Scholar]
- a He J.; Nguyen A. T.; Zhang Y. KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia. Blood 2011, 117, 3869–3880. 10.1182/blood-2010-10-312736. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Yang J.; Jubb A. M.; Pike L.; Buffa F. M.; Turley H.; Baban D.; Leek R.; Gatter K. C.; Ragoussis J.; Harris A. L. The Histone Demethylase JMJD2B Is Regulated by Estrogen Receptor and Hypoxia, and Is a Key Mediator of Estrogen Induced Growth. Cancer Res. 2010, 70, 6456–6466. 10.1158/0008-5472.can-10-0413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- De Santa F.; Totaro M. G.; Prosperini E.; Notarbartolo S.; Testa G.; Natoli G. The histone H3 lysine-27 demethylase jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 2007, 130, 1083–1094. 10.1016/j.cell.2007.08.019. [DOI] [PubMed] [Google Scholar]
- a Chang K.-H.; King O. N. F.; Tumber A.; Woon E. C. Y.; Heightman T. D.; McDonough M. A.; Schofield C. J.; Rose N. R. Inhibition of Histone Demethylases by 4-Carboxy-2,2′-Bipyridyl Compounds. ChemMedChem 2011, 6, 759–764. 10.1002/cmdc.201100026. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Hamada S.; Suzuki T.; Mino K.; Koseki K.; Oehme F.; Flamme I.; Ozasa H.; Itoh Y.; Ogasawara D.; Komaarashi H.; Kato A.; Tsumoto H.; Nakagawa H.; Hasegawa M.; Sasaki R.; Mizukami T.; Miyata N. Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone demethylase inhibitors. J. Med. Chem. 2010, 53, 5629–5638. 10.1021/jm1003655. [DOI] [PubMed] [Google Scholar]; c Luo X.; Liu Y.; Kubicek S.; Myllyharju J.; Tumber A.; Ng S.; Che K. H.; Podoll J.; Heightman T. D.; Oppermann U.; Schreiber S. L.; Wang X. A selective inhibitor and probe of the cellular functions of jumonji c domain-containing histone demethylases. J. Am. Chem. Soc. 2011, 133, 9451–9456. 10.1021/ja201597b. [DOI] [PMC free article] [PubMed] [Google Scholar]; d Rose N. R.; Ng S. S.; Mecinović J.; Liénard B. M. R.; Bello S. H.; Sun Z.; McDonough M. A.; Oppermann U.; Schofield C. J. Inhibitor Scaffolds for 2-Oxoglutarate-Dependent Histone Lysine Demethylases. J. Med. Chem. 2008, 51, 7053–7056. 10.1021/jm800936s. [DOI] [PubMed] [Google Scholar]
- Marcus A. P.; Lee A. S.; Davis R. L.; Tantillo D. J.; Sarpong R. Pronounced steric effects of substituents in the nazarov cyclization of aryl dienyl ketones. Angew. Chem., Int. Ed. 2008, 47, 6379–6383. 10.1002/anie.200801542. [DOI] [PubMed] [Google Scholar]
- Li J.; Derstine B.; Itoh T.; Balsells J. An improved preparation and a new application of trichloromethylcarbinols from enolizable ketones. Tetrahedron Lett. 2014, 55, 3151–3153. 10.1016/j.tetlet.2014.03.118. [DOI] [Google Scholar]
- CCDC 1429028(18) contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
- Li J.; Wang S.; Crispino G. A.; Tenhuisen K.; Singh A.; Grosso J. A. Selective removal of a benzyl protecting group in the presence of an aryl chloride under gaseous and transfer hydrogenolysis conditions. Tetrahedron Lett. 2003, 44, 4041–4043. 10.1016/s0040-4039(03)00846-3. [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.